| ID | Sequence | Length | GC content |
|---|---|---|---|
| GCAGUGCGGCGCCUAGAGGGAAAGCGAGAGGGAGACGGACGUUGAGAGA… | 2397 nt | 0.5315 | |
| GCAGUGCGGCGCCUAGAGGGAAAGCGAGAGGGAGACGGACGUUGAGAGA… | 2232 nt | 0.5305 | |
| GCAGUGCGGCGCCUAGAGGGAAAGCGAGAGGGAGACGGACGUUGAGAGA… | 1315 nt | 0.5148 | |
| GCAGUGCGGCGCCUAGAGGGAAAGCGAGAGGGAGACGGACGUUGAGAGA… | 2400 nt | 0.5317 | |
| GCAGUGCGGCGCCUAGAGGGAAAGCGAGAGGGAGACGGACGUUGAGAGA… | 2415 nt | 0.5313 |
This gene encodes a multifunctional protein that is involved in various cellular processes, including gene expression, cell signaling, and RNA processing and transport. The protein includes an N-terminal transcriptional activation domain and a C-terminal RNA-binding domain. Chromosomal translocations between this gene and various genes encoding transcription factors result in the production of chimeric proteins that are involved in tumorigenesis. These chimeric proteins usually consist of the N-terminal transcriptional activation domain of this protein fused to the C-terminal DNA-binding domain of the transcription factor protein. Mutations in this gene, specifically a t(11;22)(q24;q12) translocation, are known to cause Ewing sarcoma as well as neuroectodermal and various other tumors. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 1 and 14. [provided by RefSeq, Jul 2009] CIViC Summary for EWSR1 Gene Fusions between EWSR1 and multiple 3` partners are regularly identified in soft tissue sarcomas and can aid in differential diagnosis. The fusion product usually contains the N-terminal transcription-activating domain of EWSR1 and the C-terminal DNA-binding domain of the fusion partner, generating a novel transcription factor.
No relevant information is available at the moment.